Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)

• Principais autores: Kristian Reich (Autor), Luca Bianchi (Autor), Abdallah Khemis (Autor), Julia-Tatjana Maul (Autor), Athanasios Tsianakas (Autor), Christoph M. Schempp (Autor), Kim Petersen (Autor), Mia M. Noergaard (Autor), Lluis Puig (Autor)
• Formato: Livro
• Publicado em: Adis, Springer Healthcare, 2024-02-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Abstract Introduction Despite improved treatment options for plaque psoriasis within the last decades, some patients still have an inadequate response to treatment. Direct clinical evaluation between therapies used after biologic failure could facilitate physicians' choice of treatment. Methods...